Objective: Programme implementers have argued that the increasing availability of antiretroviral therapy (ART) will reduce the stigma of HIV. We analyzed data from Uganda to assess how HIV-related stigma has changed during a period of ART expansion.
Introduction
In low-income and middle-income countries (LMICs), HIV-related stigma has been associated with reduced uptake of voluntary counseling and testing [1, 2] and increased sexual risk-taking behavior [3] in the general population. Among people living with HIV (PLHIV), stigma has been associated with emotional distress [4, 5] , decreased adherence to antiretroviral therapy (ART) [6, 7] , and reduced likelihood of HIV status disclosure [8, 9] . One argument for increasing access to ART was that doing so would reduce stigma [10, 11] through improvements in physical health and HIV-related symptom burden [12] leading to economic rehabilitation and social reintegration [13, 14] . However, the extent to which levels of HIV-related stigma have actually changed in LMICs during the past decade of treatment scale up is unclear. A better understanding of temporal trends in stigma in LMICs would help elucidate the impact of ART availability on stigma and the potential need for interventions beyond ART to reduce stigma.
We attempted to address this question using serial crosssections of data from two sources: the Uganda AIDS Rural Treatment Outcomes (UARTO) study, a longitudinal cohort study of PLHIV in southwestern Uganda that initiates ART upon enrollment; and the Uganda Demographic and Health Surveys (DHS) [15, 16] , which were nationally representative, population-based surveys conducted in Uganda in 2006 and 2011. Analyzing data from UARTO allowed us to examine temporal trends in internalized stigma among PLHIV newly initiating ART [17, 18] , whereas the DHS allowed us to examine trends in stigmatizing attitudes (i.e., expressions of social distance) [18, 19] and fears about disclosure (i.e., anticipated stigma) [17, 20] in the general population. We had two specific aims: (a) to estimate temporal trends in internalized stigma from 2007 to 2012 among PLHIV presenting for ART initiation and (b) to understand temporal trends in stigmatizing attitudes and fears about disclosure among persons in the general community.
Methods
Uganda AIDS Rural Treatment Outcomes study The UARTO study enrolls participants from the Mbarara Regional Referral Hospital Immune Suppression Clinic, Mbarara, Uganda, an HIV clinic serving the Mbarara district (population 1.1 million, 92% in rural areas) and adjacent districts [21] . Participants were eligible for enrollment in the UARTO cohort if they were treatment-naive and newly initiating ART, were at least 18 years of age, and lived within 60 kilometers of the clinic. Forty-nine percent of patients who were approached for study participation agreed to be enrolled. At the pretreatment baseline visit, participants underwent blood draws and structured interviews conducted in the local language, Runyankole. The scale for measuring internalized stigma (described in more detail below) was added to the study questionnaire beginning in August 2007. Therefore, only participants whose baseline visits occurred between August 2007 and December 2012 were included in this analysis.
Study staff obtained signed, or in case of illiteracy, thumbprint-indicated informed consent from all participants. Ethical approval for study procedures was obtained from ethical review committees at the University of California at San Francisco, San Francisco, California, USA, Partners Healthcare, Boston, Massachusetts, USA, and the Mbarara University of Science and Technology, Mbarara, Uganda. Consistent with national guidelines, we received clearance for the study from the Uganda National Council for Science and Technology, Kampala, Uganda and from the Research Secretariat in the Office of the President, Kampala, Uganda.
The primary outcome of interest was internalized stigma, as measured with the six-item Internalized AIDS-Related Stigma Scale (IARSS) [22] . The IARSS has demonstrated a coherent internal structure and good reliability and construct validity among PLHIV in Uganda [9, 23] . Two scale items relate to concerns about disclosure (felt stigma) [24] and four items relate to feelings of shame and/or selfhatred [25] (see Table 1 ). Among study participants at enrollment, the estimated scale reliability coefficient for the IARSS was 0.89.
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AIDS 2015, Vol 29 No 1 Explanatory variables of interest measured at ART initiation included physical health status, CD4 þ T-lymphocyte cell count, BMI, depression symptom severity, and sociodemographic variables. Physical health status was measured using the Medical Outcomes Study-HIV Health Survey Physical Health Summary (PHS) score [26] . Depression symptom severity was measured as a continuous variable using the depression sub-scale of the Hopkins Symptom Checklist (HSCL-D) [27] . The scale was adapted for the Ugandan context [28, 29] , with the four somatic items deleted to avoid possible overlap between symptoms of depression and symptoms of HIV infection [30] . Among study participants at enrollment, the estimated scale reliability coefficient for the modified HSCL-D was 0.86.
Sociodemographic variables included age, sex, educational attainment, marital status, household asset wealth, employment status, and travel time to/from clinic. Household asset wealth was measured by applying principal components analysis to a series of 25 binary variables for household-owned assets and housing characteristics [31] . The first principal component was retained and used to define the wealth index and was entered into the regression models as a continuous variable, with higher values indicating greater asset wealth. Self-reported travel time to/from clinic was included as a proxy for rural residence.
Uganda Demographic and Health Surveys
The Uganda DHS are nationally representative, population-based surveys that were conducted in Uganda in 2006 and 2011. Each iteration of the DHS used a stratified two-stage cluster sampling design based on the sampling frame from the 2002 population census. By design, the majority of participants were women. Details of the sampling procedures are included in the full published reports [15, 16] . We limited our analyses to participants in the southwest region of Uganda (the region from which the participants in the UARTO study were drawn).
The primary outcomes of interest from the DHS were fears about disclosure and stigmatizing attitudes. Fear of disclosure was assessed by the question 'If a member of your family got infected with the AIDS virus, would you want it to remain a secret or not?' Positive responses to this question reflect anticipated stigma in the general population [20] -similar to felt stigma that may be experienced by PLHIV [24] -or the expectation of rejection were one to test HIV positive and the test result revealed to others [17] . Stigmatizing attitudes were assessed by three questions: 'If a member of your family became sick with AIDS, would you be willing to care for her or him in your own household?', ' Would you buy fresh vegetables from a shopkeeper or vendor if you knew that this person had the AIDS virus?', and 'In your opinion, if a female teacher has the AIDS virus but is not sick, should she be allowed to continue teaching in the school?' Positive responses to these questions reflect expressions of social distance [18] or an unwillingness to engage in certain forms of interaction with PLHIV (often motivated by instrumental concerns about casual transmission [19] ). A binary composite variable was created from these three questions, equal to one if the participant expressed at least one stigmatizing attitude. As a sensitivity analysis, an ordinal composite variable was also created, with values ranging from zero (answering no to all three questions) to three (answering yes to all three questions).
Sociodemographic variables, including age, sex, educational attainment, marital status, household asset wealth [31] , and employment status were included in the analysis as potential confounders of the relationship between time and stigma. We also included a composite HIV knowledge variable equal to the number of correct responses to six questions about HIV prevention and transmission (Appendix 1, http://links.lww.com/QAD/A587).
Statistical analysis
To summarize changes in internalized stigma at time of ART initiation among UARTO participants by year of cohort entry, we estimated mean stigma (IARSS) scores among participants with complete data on the variables of interest. To estimate changes in IARSS scores over time, we fitted a linear regression model with robust standard errors to the data with IARSS as the outcome variable and year of cohort entry as the explanatory variable. A statistically significant regression coefficient was considered evidence that stigma among PLHIV at ART initiation was changing over time. As an alternative parameterization, we fitted a linear regression model specifying time as a series of dummy variables for each 1-year period, using a Wald-type F test to test the joint statistical significance of the time dummy variables. Estimates were adjusted for sociodemographic characteristics measured at ART initiation as described above.
To determine whether temporal trends in clinical factors at presentation could explain observed stigma trends in the UARTO cohort, we sequentially added clinical explanatory variables (BMI, CD4 þ count, PHS, and HSCL-D) to the regression model and then reassessed the statistical significance of the regression coefficient for year of cohort entry.
To summarize changes in fears about disclosure and stigmatizing attitudes in the DHS sample (among respondents living in southwestern Uganda only), we merged the 2006 and 2011 datasets into a single dataset with year of DHS as a variable. We used two-sample tests of proportions to compare fears about disclosure and stigmatizing attitudes between 2006 and 2011. To adjust for changes in sociodemographic characteristics, we fitted logistic regression models to the data with year of DHS and sociodemographic variables as explanatory variables. Using these multivariable models, we then sought to identify whether changes in knowledge of HIV explained changes in stigma by adding the composite knowledge variable to the models and reassessing the statistical significance of the year indicator.
All analyses were performed using SAS software (Version 9.3; SAS Institute, Cary, North Carolina, USA). Regression diagnostic procedures yielded no evidence of collinearity or overly influential outliers in any of the models. Because our analyses of the DHS were limited to participants living in southwestern Uganda, we did not apply survey weights or clustering variables to obtain nationally representative estimates.
Results
Temporal trends in internalized stigma among Uganda AIDS Rural Treatment Outcomes participants There were 229 women (70%) and 100 men (30%) in the sample for whom complete case data were available (see Appendix 2, http://links.lww.com/QAD/A587 for details). Because of restructuring of study administration and interruption in salary support for study staff, recruitment was limited to 10 participants in 2010. Baseline characteristics are described in Table 1 .
Mean stigma scores by year of cohort entry are shown in Fig. 1 ; in item-by-item analyses, statistically significant upward trends were observed for all items except for the item 'I sometimes feel worthless because I am HIV positive' (b ¼ 0.02, P ¼ 0.06). In a univariable analysis, a statistically significant positive association between year of entry and IARSS score was observed (b ¼ 0.17; 95% CI, 0.05-0.28). This suggests an 11.0% (0.17/1.54 ¼ 0.11) increase per year, relative to the baseline value, in the mean internalized stigma score among newly enrolled participants at cohort entry. The alternative parameterization specifying time as a series of dummy variables was consistent with this finding, rejecting the null hypothesis that mean IARSS score at ART initiation was constant across time (F ¼ 3.77, P ¼ 0.003).
After multivariable adjustment for baseline sociodemographic characteristics, the adjusted regression coefficient for year of cohort entry remained statistically significant (b ¼ 0.18; 95% CI, 0.06-0.30) ( Table 2 ). The statistical significance remained unchanged with the addition of each of the clinical explanatory variables of interest (PHS, BMI, CD4 þ cell count, or HSCL-D) to the multivariable linear regression model, suggesting that changes over time in health status at ART initiation did not explain the observed trend towards increasing stigma.
Temporal trends in stigmatizing attitudes and fears of disclosure in southwestern Uganda Complete case data (see Appendix 2, http://links.lww. com/QAD/A587) on persons living in southwestern Uganda were available on 1141 participants in the 2006 DHS and 1106 participants in the 2011 DHS (Table 3) . 86 AIDS 2015, Year of entry N Internalized AIDS-related stigma scale, mean score Comparing 2006 and 2011, statistically significant differences were found in stigmatizing attitudes and fears about disclosure. Respondents in 2011 were more likely to display an accepting attitude on all three indicators of stigmatizing attitudes (59 vs. 46%, x 2 ¼ 38.2, P < 0.001). However, respondents in 2011 were also more likely to endorse fears about disclosure (61 vs. 47%, x 2 ¼ 43.4, P < 0.001). Adjustment for sociodemographic variables and HIV knowledge yielded no substantive changes in these findings (Table 4 ).
Discussion
In this analysis of data from southwestern Uganda, we observed an increase over time in internalized stigma among PLHIV initiating ART. This increase was not explained by compositional changes in sociodemographic characteristics, health status, or psychosocial well being at treatment initiation. During the same time period, we observed that a significantly higher percentage of people in the general population endorsed fears about disclosure despite an apparent increase in accepting attitudes towards PLHIV. Our findings suggest that the expansion of ART alone may be insufficient to reduce HIV-related stigma and that further targeted efforts to counter stigma are necessary, such as educational campaigns [32] , changes to laws or policies that institutionalize stigma [7] , and/or livelihood interventions [10] .
Our analysis of the 2006 and 2011 DHS suggests that anticipated stigma has worsened in the community despite a decline in stigmatizing attitudes towards PLHIV. What could explain these divergent trends in the general population? Social desirability bias may offer one potential explanation [33] . Namely, the widely disseminated HIV prevention campaigns in Uganda [34, 35] may have sensitized people to knowing how they ought to feel about PLHIV without actually changing how they actually feel about PLHIV. This could potentially explain why anticipated stigma increased (i.e., respondents expressed fear of disclosure in the event of a hypothetical case of HIV infection in their family) even while indicators of stigmatizing attitudes declined (i.e., because respondents increasingly understand that they should endorse accepting attitudes towards PLHIV). An alternative interpretation is that although respondents may have actually changed their own attitudes towards PLHIV, they may have perceived that others in society have not. Thus, the trend towards increasing acceptance of PLHIV may reflect respondents' true feelings, but the belief that such attitudes remain prevalent in society may result in persistent fears of disclosure.
In turn, the persistence of fears about disclosure in the community could adversely affect PLHIV through two hypothesized social psychological mechanisms (explained by Link et al. [18] in the context of mental illness stigma). First, during socialization, PLHIV may devalue themselves because they see themselves as belonging to a person group that most others in the general population view negatively. Second, PLHIV who are concerned about the stigmatizing attitudes held by others will engage in negative defenses such as covering and isolation. Either or both of these mechanisms could explain why internalized stigma among PLHIV increased over time.
Persistent HIV-related stigma in Uganda Chan et al. 87 It remains unclear whether our findings reflect trends in other populations in sub-Saharan Africa. Programme implementers from Partners in Health [11, 36] as well as investigators in South Africa [37] , Botswana [20] , Uganda [10, 12] , and Malawi [38] have argued that the increasing availability of ART should be associated with reduced levels of stigma in the general population. This experience has not been observed universally. For example, Maughan-Brown [39] found an increase in several dimensions of stigma among the general population of South Africa in 2003-2006 despite ART expansion. This finding may be related to the idea that ART does little to counter persistent blaming attitudes and feelings of moral outrage in the community; indeed, ART may be perceived as allowing PLHIV to appear healthy enough to engage in promiscuous behaviors and spread HIV [39] [40] [41] . Niehaus [42] , on the other hand, argued that any association with perceived deviance provides an insufficient explanation for persisting negative attitudes towards PLHIV. Lack of trust among the general population in the efficacy and sustainability of ART may also mitigate the positive effects of ART expansion on stigma [43, 44] . Finally, Maughan-Brown studied only the earliest period of treatment expansion. With additional observation periods, it is possible that the trends observed in his study would have changed.
We contend that there is reason to believe that our findings may be unique to Uganda and that the persistence of stigma may be related to the country's status as the only country in sub-Saharan Africa to have experienced an increasing incidence of HIV in the past decade [45, 46] . Formerly hailed as an HIV/AIDS 'success story' [47] , Uganda's achievements in controlling the spread of HIV have stalled as the number of new infections per year in Uganda has increased from approximately 69 000 in 2001 to 120 000 in 2012 [45] .
There is growing concern that the recent drafting of antihomosexuality legislation may have increased HIVrelated stigma and discouraged people from being tested and treated [48] [49] [50] . Moreover, many observers fear that HIV-related stigma will be further exacerbated by recently passed legislation that criminalizes 'willful' HIV transmission and permits medical providers to disclose a patient's HIV status to others [49, 51] . Given the urgent need to reduce new HIV infections and HIVrelated deaths in Uganda, further investigation into the relationship between stigma and persistently high HIV incidence as well as interventions to reduce HIV-related stigma may be warranted.
There are several limitations to our study. First, our data are derived from a single region of Uganda. Regional heterogeneity in stigmatizing attitudes has been described [52] . Furthermore, as discussed above, it is uncertain whether our findings represent a trend unique to Uganda or reflect trends that exist in other LMICs. The IARSS scores in the UARTO cohort (mean ¼ 1.5) appeared to be lower compared with those obtained in surveys conducted in South Africa (mean ¼ 3.0) and Swaziland (mean ¼ 2.2) [22] . These differences may be due to the fact that those data were collected in hyperendemic settings during an earlier time period compared with the UARTO cohort. Second, our measures of anticipated stigma and social distance, which are also used as core indicators for monitoring the HIV epidemic by the Joint United Nations Programme on HIV/AIDS [53] , describe hypothetical situations that survey respondents could have misunderstood without being provided with further information. Although this limitation is well known [33, 54] , it would only lead to biased estimates of temporal trends in stigma if respondents' comprehension of these specific questions were also systematically changing over time. Third, the study sample of PLHIV consisted primarily of women. However, this is typical of other HIV cohorts in sub-Saharan Africa. For example, in the meta-analysis of more than 200 000 PLHIV by Druyts et al. [55] , nearly two-thirds of participants were women. Similar findings were reported by Muula et al. [56] . Fourth, we were unable to evaluate the role of healthcare providers' attitudes towards PLHIV as a contributing factor to the increase in internalized stigma among PLHIV; although participants in the UARTO cohort were ART-naive, about half of them had had previous contact with HIV providers. Because disrespect of PLHIV among providers in sub-Saharan Africa has been shown to be a potentially important cause of disengagement from HIV care [57] , further study on trends in healthcare providers' attitudes would be helpful in understanding the reasons for increasing internalized stigma among PLHIV.
In conclusion, in this study of rural southwestern Uganda, we found evidence for a temporal trend of increasing stigma among PLHIV presenting for ART initiation as well as persisting anticipated stigma among the general population. Despite the growing availability of ART, which has allowed increasing numbers of PLHIV to restore physical health and rehabilitate economically and socially, these forms of stigma remain highly prevalent and may have worsened. Our findings underscore the need to better understand reasons for persistent stigma in the era of ART expansion and more effective methods to reduce stigma among PLHIVand in the general population.
